143 related articles for article (PubMed ID: 25730301)
1. Contrast media controversies in 2015: imaging patients with renal impairment or risk of contrast reaction.
Davenport MS; Cohan RH; Ellis JH
AJR Am J Roentgenol; 2015 Jun; 204(6):1174-81. PubMed ID: 25730301
[TBL] [Abstract][Full Text] [Related]
2. Incidence of nonconfounded post-computed tomography acute kidney injury in hospitalized patients with stable renal function receiving intravenous iodinated contrast material.
Moore A; Dickerson E; Dillman JR; Vummidi D; Kershaw DB; Khalatbari S; Davenport MS
Curr Probl Diagn Radiol; 2014; 43(5):237-41. PubMed ID: 24909428
[TBL] [Abstract][Full Text] [Related]
3. Incidence of CT Contrast Agent-Induced Nephropathy: Toward a More Accurate Estimation.
Garfinkle MA; Stewart S; Basi R
AJR Am J Roentgenol; 2015 Jun; 204(6):1146-51. PubMed ID: 26001222
[TBL] [Abstract][Full Text] [Related]
4. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.
Davenport MS; Khalatbari S; Cohan RH; Dillman JR; Myles JD; Ellis JH
Radiology; 2013 Sep; 268(3):719-28. PubMed ID: 23579046
[TBL] [Abstract][Full Text] [Related]
5. Risk of acute kidney injury after exposure to gadolinium-based contrast in patients with renal impairment.
Chien CC; Wang HY; Wang JJ; Kan WC; Chien TW; Lin CY; Su SB
Ren Fail; 2011; 33(8):758-64. PubMed ID: 21777176
[TBL] [Abstract][Full Text] [Related]
6. Incidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiography.
Morabito S; Pistolesi V; Benedetti G; Di Roma A; Colantonio R; Mancone M; Sardella G; Cibelli L; Ambrosino M; Polistena F; Pierucci A
J Nephrol; 2012; 25(6):1098-107. PubMed ID: 22383347
[TBL] [Abstract][Full Text] [Related]
7. Anemia and the risk of contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT.
Murakami R; Kumita S; Hayashi H; Sugizaki K; Okazaki E; Kiriyama T; Hakozaki K; Tani H; Miki I; Takeda M
Eur J Radiol; 2013 Oct; 82(10):e521-4. PubMed ID: 23827802
[TBL] [Abstract][Full Text] [Related]
8. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
[TBL] [Abstract][Full Text] [Related]
9. Contrast-Induced Nephropathy: Identifying the Risks, Choosing the Right Agent, and Reviewing Effective Prevention and Management Methods.
Nicola R; Shaqdan KW; Aran K; Mansouri M; Singh A; Abujudeh HH
Curr Probl Diagn Radiol; 2015; 44(6):501-4. PubMed ID: 26072134
[TBL] [Abstract][Full Text] [Related]
10. [Renal toxicity of contrast agents in oncologic patients].
Amet S; Deray G
Bull Cancer; 2012 Mar; 99(3):295-307. PubMed ID: 22082610
[TBL] [Abstract][Full Text] [Related]
11. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
13. Impact of benazepril on contrast-induced acute kidney injury for patients with mild to moderate renal insufficiency undergoing percutaneous coronary intervention.
Li XM; Cong HL; Li TT; He LJ; Zhou YJ
Chin Med J (Engl); 2011 Jul; 124(14):2101-6. PubMed ID: 21933609
[TBL] [Abstract][Full Text] [Related]
14. Renal function-adjusted contrast volume redefines the baseline estimation of contrast-induced acute kidney injury risk in patients undergoing primary percutaneous coronary intervention.
Andò G; de Gregorio C; Morabito G; Trio O; Saporito F; Oreto G
Circ Cardiovasc Interv; 2014 Aug; 7(4):465-72. PubMed ID: 25027519
[TBL] [Abstract][Full Text] [Related]
15. Clinically significant contrast induced acute kidney injury after non-emergent cardiac catheterization--risk factors and impact on length of hospital stay.
Kashif W; Khawaja A; Yaqub S; Hussain SA
J Coll Physicians Surg Pak; 2013 Dec; 23(12):842-7. PubMed ID: 24304985
[TBL] [Abstract][Full Text] [Related]
16. Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency.
Ledneva E; Karie S; Launay-Vacher V; Janus N; Deray G
Radiology; 2009 Mar; 250(3):618-28. PubMed ID: 19244037
[TBL] [Abstract][Full Text] [Related]
17. A simple preprocedural score for risk of contrast-induced acute kidney injury after percutaneous coronary intervention.
Chen YL; Fu NK; Xu J; Yang SC; Li S; Liu YY; Cong HL
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E8-16. PubMed ID: 23907993
[TBL] [Abstract][Full Text] [Related]
18. Contrast-induced acute kidney injury: how much contrast is safe?
Keaney JJ; Hannon CM; Murray PT
Nephrol Dial Transplant; 2013 Jun; 28(6):1376-83. PubMed ID: 23413087
[TBL] [Abstract][Full Text] [Related]
19. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate.
McDonald JS; McDonald RJ; Carter RE; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2014 Apr; 271(1):65-73. PubMed ID: 24475854
[TBL] [Abstract][Full Text] [Related]
20. Contrast-induced nephropathy in percutaneous coronary interventions: pathogenesis, risk factors, outcome, prevention and treatment.
Aurelio A; Durante A
Cardiology; 2014; 128(1):62-72. PubMed ID: 24557146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
